Chinook Therapeutics/ US16961L1061 /
2023-08-10 10:29:02 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
40.35USD | - | 58,595 Turnover: 2.36 mill. |
-Bid Size: - | -Ask Size: - | 40.50 | 40.29 |
GlobeNewswire
03-14
IgA Nephropathy Pipeline Dynamics Signal Further Treatment Evolution on the Horizon
GlobeNewswire
2023-11-16
Jeremy Caldwell, Ph.D., Accomplished Biopharma Executive, Company Creator and R&D Leader, Joins Red ...
GlobeNewswire
2022-03-21
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
2022-03-17
Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financia...
GlobeNewswire
2022-03-08
Chinook Therapeutics to Present at Oppenheimer’s 32nd Annual Healthcare Conference
GlobeNewswire
2022-02-09
Chinook Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
GlobeNewswire
2022-02-04
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
2022-01-24
Chinook Therapeutics Announces Appointment of Charlotte Jones-Burton, M.D., M.S. as Senior Vice Pres...
GlobeNewswire
2021-12-14
Chinook Therapeutics Receives Orphan Drug Designation from European Commission for Atrasentan for Tr...
GlobeNewswire
2021-11-15
Chinook Therapeutics Announces Closing of $183.5 Million Public Offering, Including Full Exercise of...
GlobeNewswire
2021-11-10
Chinook Therapeutics Announces Pricing of an Upsized $160 Million Public Offering
GlobeNewswire
2021-11-08
Chinook Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
GlobeNewswire
2021-11-04
Chinook Therapeutics Presents Data from BION-1301 Phase 1/2 Trial in Patients with IgA Nephropathy (...
GlobeNewswire
2021-10-15
Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call During the A...
GlobeNewswire
2021-08-12
Chinook Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
GlobeNewswire
2021-07-12
Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2021
GlobeNewswire
2021-07-07
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)